Investment Q&A

Q: Visa has been sporadic as of late. Might switching to JPMorgan within the Financial sector be a valid move?

Q: Why is Blackstone Inc. (BX) falling so much and is it a good time to buy? What's the long term prognosis for this company.

Can you please comment on this...."Blackstone allowed investors to redeem 7% of the $82 billion fund in the first quarter, exceeding the typical 5% withdrawal limit. Blackstone employees redeemed an additional 0.9% of the fund.

In all, Blackstone allowed investors to pull $3.7 billion out of its namesake private credit fund, commonly referred to as BCRED. The fund saw new commitments of $2 billion, leaving it with $1.7 billion worth of net withdrawals.

The news is expected to have ripples across the private credit sector, which already has been under stress in light of developments at Blue Owl Capital. The fund sold $1.4 billion in assets and halted redemptions at its private retail debt fund last month, rattling investor confidence."

Q: Hello Team 5i & Everyone,

If no one has already asked, may I please have your take on Crowdstrikes earnings?

Thank you!

Sandra

Q: Hello 5i,
Could I have your assessment of these stocks; Q, KEYS, GLW.
Thank you
Dave

Q: Dear Peter et al:


I am long term holder of CSCO. I have made decent profit. Sometime ago to my question, you mentioned that it can be held still didn't see any problem with it.
But more recently I am hearing rumblings that ANET is better suited for AI going forward? Should one switch? It is in my Regd a/c. So, no tax implications.

Q: When looking at technical analysis of this company, would one need to ignore the chart action prior to March 2022 because of its spin-off ? - i.e. is it irrelevant to use stock pricing before that date to establish overall long term trend lines and channels for T.A. purposes ?

How do you see this company as an investment going forward, and how do its valuation metrics compare now to the past?

Q: The most recent quarter seems to be quite positive in terms of growth and profitability trajectory - how would you assess the quarter and does this confirm a rebound for the stock or reconfirm worries?

Q: May I have your thoughts on AEVA? They reported recently and it seems Barrons has stated the company has reached an “inflection point”, whatever that means. The stock has been strong since reporting it’s earnings last week.
I confirm I have clicked on Public Question so if it comes to you as Private Question there is some software glitch.
Regards,
Jim

Q: Can I get your thoughts on Harrow's latest quarter please? And can you please rank HROW, ISRG, LLY and TMDX for purchase/hold?
Thank you

Q: Hi 5i,

Thanks for your advise for BRK.B:US, you have mentioned that BUY at $450 (ClassB) would be a good price, and average target is $525 which seems about right to us.

Long time ago you have suggested the price buy-in around $500, seem you have getting more negative for this stock. Any reason you don’t feel positive, is that because due to the big cash $373 billion holding?

Q: Any reason for the drop today.

Q: Do you think its worth holding on to Nike at this point? I can be patient but are there better places to be?

Q: what percent of poly market is held by ICE and would it be enough to move the value of ICE should poly market eventually go public thanks Richard

Q: What is going on with AVAV today,? Down 20%. Is it a buying opportunity?

Q: Do you see, in the next 3-5 years,significant upside for these stocks?If so what would see as a good entry point for each?
Thank you

Q: I understand NVDA is putting 2Billion each into both COHR & LITE. I’m happy with COHR, up almost 400% now at a 5% weighting. Probably should start to look at selling some to keep the weighting down. Is LITE investable with its 220 P/E? One other question is NVDA getting shares for their 2 Billion?
Jim

Q: Hello Team,
Could I have your opinion on Blue Owl please.
Many thanks!

Q: The sector rotations in the markets are wreaking havoc on my portfolio balance, mostly in a good way. The healthcare sector overall is down and the limited successes seem expensive. Also, the US government is pushing pharma to reduce their margins.
Do you feel that it is a good time to invest in healthcare and if so could you recommend stocks and etfs for broader exposure? For years, the etfs seem to have underperformed.

Thank you!

Q: May I have your read on the reported earnings and prospects for CRSP please.

Q: Hi 5i,

Would you please comment the result and seem not that good. Does it relate to the new CEO? Please kindly advise the price to buy-in and the target price as well. Many thanks.